Europe • Euronext Paris • EPA:BIM • FR0013280286
Taking everything into account, BIM scores 6 out of 10 in our fundamental rating. BIM was compared to 63 industry peers in the Health Care Equipment & Supplies industry. While BIM has a great health rating, its profitability is only average at the moment. BIM has a correct valuation and a medium growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.04% | ||
| ROE | 9.61% | ||
| ROIC | 8.56% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.38% | ||
| PM (TTM) | 9.17% | ||
| GM | 56.27% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 1.15 | ||
| Altman-Z | 6.24 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.27 | ||
| Quick Ratio | 1.3 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.34 | ||
| Fwd PE | 19.54 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.38 | ||
| EV/EBITDA | 11.85 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.86% |
ChartMill assigns a fundamental rating of 6 / 10 to BIM.PA.
ChartMill assigns a valuation rating of 5 / 10 to BIOMERIEUX (BIM.PA). This can be considered as Fairly Valued.
BIOMERIEUX (BIM.PA) has a profitability rating of 6 / 10.
The financial health rating of BIOMERIEUX (BIM.PA) is 8 / 10.
The dividend rating of BIOMERIEUX (BIM.PA) is 3 / 10 and the dividend payout ratio is 28.07%.